Short Interest in Apollomics, Inc. (NASDAQ:APLMW) Rises By 238.5%

Apollomics, Inc. (NASDAQ:APLMW) saw a large growth in short interest during the month of September. As of September 30th, there was short interest totalling 58,900 shares, a growth of 238.5% from the September 15th total of 17,400 shares. Based on an average daily volume of 21,600 shares, the days-to-cover ratio is currently 2.7 days.

Apollomics Stock Performance

NASDAQ:APLMW opened at $0.01 on Friday. The stock’s fifty day simple moving average is $0.01 and its 200-day simple moving average is $0.02. Apollomics has a 12-month low of $0.01 and a 12-month high of $0.10.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.